RESUMO
Literature data concerning modern notions about the role of taurine in the central nervous system are analyzed. Mechanisms of the neuroprotective activity of taurine are described. Evidence showing the effects of taurine as neurotransmitter, neuromodulator, antioxidant, etc. is provided.
Assuntos
Antioxidantes/farmacocinética , Sistema Nervoso Central/metabolismo , Neurotransmissores/farmacocinética , Taurina/farmacocinética , Animais , HumanosRESUMO
Neuroprotective properties of the new derivative of glutamic and apovincaminic acids, ethyl -(3-alpha,16-alpha)-eburnamenin-14-carbopxylate of 2-aminopentadionic acid (LHT 1-02) were studied on a model of acute brain ischemia in cats. LHT 1-02 has proved to be more effective than the reference drugs vinpocetin and glycine in preventing the reperfusive damage, which was manifested by decreased postischemic hyperglycemia, activated utilization of oxygen in the brain, and suppressed postischemic metabolic lactate acidosis. Thus, the results of this comparative study show expediency of further investigations of LHT 1 - 02 as a potential neuroprotective drug.
Assuntos
Isquemia Encefálica/tratamento farmacológico , Encéfalo/efeitos dos fármacos , Ácido Glutâmico/farmacologia , Fármacos Neuroprotetores/farmacologia , Traumatismo por Reperfusão/tratamento farmacológico , Alcaloides de Vinca/farmacologia , Acidose Láctica/prevenção & controle , Animais , Glicemia/metabolismo , Encéfalo/metabolismo , Isquemia Encefálica/metabolismo , Gatos , Ácido Glutâmico/análogos & derivados , Ácido Glutâmico/síntese química , Glicina/farmacologia , Ácido Láctico/antagonistas & inibidores , Ácido Láctico/biossíntese , Fármacos Neuroprotetores/síntese química , Consumo de Oxigênio/efeitos dos fármacos , Traumatismo por Reperfusão/metabolismo , Alcaloides de Vinca/químicaRESUMO
Comparative study of antihypoxic activity of glutamic and N-acetylglutamic acid in doses of 1, 10, 50 and 100 mg/kg was realized. It was experimentally ascertained that the most apparent antihypoxic action of study objects occurs in conditions of hypobaric hypoxia of acetylated derivative of glutamic acid considerably exceeds glutamic acid.
Assuntos
Glutamatos/farmacologia , Ácido Glutâmico/farmacologia , Hipercapnia/prevenção & controle , Hipóxia/prevenção & controle , Longevidade/efeitos dos fármacos , Animais , Relação Dose-Resposta a Droga , Hipercapnia/fisiopatologia , Hipóxia/fisiopatologia , Injeções Intraperitoneais , Camundongos , Camundongos Endogâmicos CBA , Nitroprussiato/farmacologia , Nitrito de Sódio/farmacologiaAssuntos
Citoproteção/efeitos dos fármacos , Epinefrina/toxicidade , Taurina/farmacologia , Animais , Animais não Endogâmicos , Artérias/efeitos dos fármacos , Artérias/metabolismo , Cálcio/sangue , Cérebro/efeitos dos fármacos , Cérebro/metabolismo , Doença Crônica , Modelos Animais de Doenças , Lipídeos/sangue , Masculino , Ratos , Veias/efeitos dos fármacos , Veias/metabolismoAssuntos
Isquemia Encefálica/patologia , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Oxirredutases/metabolismo , Taurina/farmacologia , Animais , Encéfalo/patologia , Isquemia Encefálica/metabolismo , Artéria Carótida Primitiva/patologia , Sobrevivência Celular/efeitos dos fármacos , Oclusão Coronária/metabolismo , Oclusão Coronária/patologia , Modelos Animais de Doenças , Formazans/química , Camundongos , Fármacos Neuroprotetores/farmacologiaRESUMO
Effect of magnesium sulfate (50 and 100 mg/kg) as a corrector of postishemic brain injury has been experimentally studied. It is established that both therapeutic and preventive introduction of magnesium sulfate limits early postishemic hypoperfusion and hypotension.
Assuntos
Isquemia Encefálica/tratamento farmacológico , Encéfalo/efeitos dos fármacos , Circulação Cerebrovascular/efeitos dos fármacos , Sulfato de Magnésio/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Traumatismo por Reperfusão/prevenção & controle , Animais , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Encéfalo/irrigação sanguínea , Isquemia Encefálica/complicações , Isquemia Encefálica/fisiopatologia , Relação Dose-Resposta a Droga , Sulfato de Magnésio/administração & dosagem , Masculino , Fármacos Neuroprotetores/administração & dosagem , Ratos , Ratos Wistar , Traumatismo por Reperfusão/etiologia , Traumatismo por Reperfusão/fisiopatologiaRESUMO
The effect of glucosamine sulfate on the analgesic properties and ulcerogenic action of ketoprofen has been experimentally studied in the course of drug adminstration in laboratory animals in comparison to the ketoprofen monotherapy. An analysis of the results shows that the combined application of glucosamine sulfate with ketoprofen produces a twofold increase in the analgesic activity of ketoprofen and decreases the drug-induced damage of the stomach mucous membrane. These effects are especially pronounced for the following ratio of components: ketoprofen, 16 or 24 mg/kg; glucosamine sulfate, 125 mg/kg.
Assuntos
Analgésicos não Narcóticos/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Glucosamina/farmacologia , Cetoprofeno/farmacologia , Limiar da Dor/efeitos dos fármacos , Úlcera Gástrica/prevenção & controle , Analgésicos não Narcóticos/toxicidade , Animais , Anti-Inflamatórios não Esteroides/toxicidade , Cetoprofeno/toxicidade , Masculino , Medição da Dor , Ratos , Ratos Wistar , Úlcera Gástrica/induzido quimicamenteRESUMO
The antihypoxant activity of glycine and its phosphorilated derivative AKF 90-7 in doses 1, 20, 50 and 100 mg/kg was studied. AKF 90-7 increases the survival of laboratory animals under the conditions of various hypoxia types. The antihypoxic effect of glycine was the same with the effect of AKF 90-7 in hystotoxic hypoxia, but absent on the model of hemic hypoxia and substantially lower than that of AKF 90-7 on the models of hypercapnic and hypobaric hypoxia.
Assuntos
Antioxidantes/administração & dosagem , Glicina/administração & dosagem , Hipóxia/tratamento farmacológico , Animais , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Glicina/análogos & derivados , Camundongos , Camundongos Endogâmicos CBARESUMO
The effect of glycine and its phosphorylated derivative (AKF 90-7) on the ischemic brain injury in experimental animals has been studied. The therapeutic injection of glycine and AKF 90-7 (50 100 mg/kg) increased the survival of laboratory animals under the conditions of ischemia caused by ligation of the carotid artery. In a dose of 50 mg/kg, AKF 90-7 was more effective than glycine in activating enzymes of the antioxidant system and preventing the formation of lipid peroxidation products.
Assuntos
Isquemia Encefálica/tratamento farmacológico , Glicina/análogos & derivados , Peroxidação de Lipídeos/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Animais , Ativação Enzimática , Glicina/farmacologia , Masculino , Fármacos Neuroprotetores/uso terapêutico , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismoRESUMO
Neuroprotector properties of a new apovincaminic acid derivative (LHT 2 - 02) were studied on a model of acute brain ischemia in cats. LHT 2 - 02 has proved to be more effective than the reference drugs vinpocetin and glycine in preventing the reperfusive damage, which was manifested by decreased postishemic hyperglycemia and suppressed postishemic metabolic lactate acidosis.
Assuntos
Isquemia Encefálica/prevenção & controle , Fármacos Neuroprotetores/uso terapêutico , Traumatismo por Reperfusão/prevenção & controle , Alcaloides de Vinca/química , Alcaloides de Vinca/uso terapêutico , Acidose Láctica/tratamento farmacológico , Animais , Gatos , Glicina/uso terapêutico , Hiperglicemia/tratamento farmacológicoRESUMO
It was experimentally established that prophylactic introduction of a Rhodiola Rosea extract prevents the ischemic brain damage development. A course administration of the drug in a dose of 700 mg/kg arrests the development of hyper- and hypoperfusion in cerebral circulation, weakens the postischemic hyperglycemic reaction, lowers oxygen extraction by cerebral tissues, suppresses lactate acidosis, promotes pyruvate participation in metabolic processes inhibits edema swelling, prevents the "calcium paradox" development, and decreases manifestations of the lipid peroxidation processes.
Assuntos
Edema Encefálico/prevenção & controle , Isquemia Encefálica/tratamento farmacológico , Circulação Cerebrovascular/efeitos dos fármacos , Fitoterapia , Rhodiola/química , Administração Oral , Animais , Encéfalo/irrigação sanguínea , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Química Encefálica/efeitos dos fármacos , Isquemia Encefálica/fisiopatologia , Catalase/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Masculino , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos , Ratos WistarRESUMO
It is suggested that radial gravitational overloads in craniocaudal direction, during which the pressure in meningeal arteries drops to zero, can be used to model the ischemic state. The post-ischemic period is characterized by increasing content of lipid peroxidation products in the venous blood and by violation of the neurological state in rats. This ischemia model, requiring no anaesthesia for the experimental animals, can be used in the directed search for new neuroprotectors and their characterization.
Assuntos
Isquemia Encefálica/metabolismo , Isquemia Encefálica/psicologia , Gravidade Alterada/efeitos adversos , Animais , Comportamento Animal , Isquemia Encefálica/etiologia , Peroxidação de Lipídeos , Fármacos Neuroprotetores/farmacologia , Ratos , Substâncias Reativas com Ácido Tiobarbitúrico , Alcaloides de Vinca/farmacologiaRESUMO
A new drug composition containing pyroglutamic acid and pyrrolidone produces a significant effect on the cerebral circulation in rats with global recurrent brain ischemia and in a model ischemic state under high radial gravitational overload. In the former case, the new drug increases the blood circulation in rats with the global ischemic damage to a greater extent than in the intact control group. Pretreatment with the pyroglutamic acid--pyrrolidone composition produced a 2-2.5-fold increase in the survival of rats in the ischemic state caused by the radial gravitational overload. The data obtained show evidence of a substantial neuroprotector action of the new drug composition.
Assuntos
Isquemia Encefálica/prevenção & controle , Fármacos Neuroprotetores/administração & dosagem , Pirrolidinonas/administração & dosagem , Ácido Pirrolidonocarboxílico/administração & dosagem , Animais , Isquemia Encefálica/etiologia , Isquemia Encefálica/fisiopatologia , Circulação Cerebrovascular/efeitos dos fármacos , Combinação de Medicamentos , Hipergravidade/efeitos adversos , Ataque Isquêmico Transitório/fisiopatologia , Ataque Isquêmico Transitório/prevenção & controle , RatosRESUMO
The paper describes the drainage systems developed by the Medinstrument Research Production Association, such as nephropyelostomic catheters, drainage tubes of the Saratoga type, surgical aspiration instruments (tips) made of flexible medical PVC of various modifications. Their testing in the leading clinics of the Russian Federation has shown that the instruments will find a wide application in urological and surgical units. Their use will take some burden from medical personnel and have its therapeutical, social, and economic impact.
Assuntos
Cateterismo/instrumentação , Drenagem/instrumentação , Polímeros , Desenho de EquipamentoRESUMO
The experiments were performed in 56 albino rats (15of them served as a control. The small intestine was excluded from the blood circulation for 45minutes and then pieces of the proximal and distal parts of the intestine were taken forhistological and histochemical study. It was shown that such a term of anemia resulted indeep but reversible changes in the mucous sheath and in the intramural nervous apparatus of thesmall intestine. The state of the organ wall became normal in 15 days after operation.